Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-25T19:32:19.448Z Has data issue: false hasContentIssue false
  • English
  • Français

Zinc Sulfate Could be a Potential Agent for the Treatment of Huntington's Disease Through Activating Central TrkB Signaling

Published online by Cambridge University Press:  07 November 2014

Chia-Liang Wu
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Information
CNS Spectrums , Volume 15 , Issue 1 , January 2010 , pp. 56 - 57
Copyright
Copyright © Cambridge University Press 2010

References

REFERENCES

1.Zuccato, C, Cattaneo, E. Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol. 2007; 81: 294–330.CrossRefGoogle ScholarPubMed
2.Ferrer, I, Goutan, E, Marín, C, Rey, MJ, Ribalta, T. Brain-derived neurotrophic factor in Huntington disease. Brain Res. 2000; 866: 257–261.Google Scholar
3.Ginés, S, Bosch, M, Marco, S, et al. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain. Eur J Neurosci. 2006; 23: 649–658.Google Scholar
4.Borrell-Pagès, M, Canals, JM, Cordelières, FP, et al. Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. J Clin Invest. 2006; 116: 1410–1424.Google Scholar
5.Kells, AP, Fong, DM, Dragunow, M, et al. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease. Mol Ther. 2004; 9: 682–688.Google Scholar
6.Bilici, M, Yildirim, F, Kandil, S, et al. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28: 181–190.Google Scholar
7.Siwek, M, Dudek, D, Paul, IA, et al. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: A double blind, placebo-controlled study. J Affect Disord. In press.Google Scholar
8.Nowak, G, Legutko, B, Szewczyk, B, et al. Zinc treatment induces cortical brain-derived neurotrophic factor gene expression. Eur J Pharmacol. 2004; 492: 57–59.Google Scholar
9.Hwang, JJ, Park, MH, Choi, SY, Koh, JY. Activation of the Trk signaling pathway by extracellular zinc. Role of metalloproteinases. J Biol Chem. 2005; 280: 11995–12001.Google Scholar
10.Sowa-Kuma, M, Legutko, B, Szewczyk, B, et al. Antidepressant-like activity of zinc: further behavioral and molecular evidence. J Neural Transm. 2008; 115: 1621–1628.Google Scholar
11.Franco, JL, Posser, T, Brocardo, PS, et al. Involvement of glutathione, ERK1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc in rats. Behav Brain Res. 2008; 188: 316–323.Google Scholar